Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study

Schrijvers, E.M.C., Witteman, J.C.M., Sijbrands, E.J.G., Hofman, A., Koudstaal, P.J., Breteler, M.M.B.·2010·Neurology
DOI 10.1212/wnl.0b013e3181ffe4f6

Cited by (328)

Items 201–300 of 328

  1. Vitamins: a nutritional intervention to modulate the Alzheimer’s disease progression
    Jahangir Alam · 2020 · Nutritional Neuroscience
  2. Application of Grey Relational Analysis to Predict Dementia Tendency by Cognitive Function, Sleep Disturbances, and Health Conditions of Diabetic Patients
    Chiung‐Yu Huang, Yu‐Ching Lin, Yung‐Chuan Lu, Chun‐I Chen · 2022 · Brain Sciences
  3. The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
    Monika Karczewska‐Kupczewska, Natalia Lelental, Agnieszka Adamska, Agnieszka Nikołajuk, Irina Kowalska, Maria Górska, Rüdiger Zimmermann, Johannes Kornhuber, Marek Strączkowski, Piotr Lewczuk · 2012 · Alzheimer s & Dementia
  4. Insulin Resistance and Alzheimer’s Disease
    Sung Min, H. Seo Joon, Inhee Mook‐Jung · 2011 · InTech eBooks
  5. Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets
    Smriti Nagpal Gupta, Nitin Kumar Singhal, Subramaniam Ganesh, Rajat Sandhir · 2018 · CNS & Neurological Disorders - Drug Targets
  6. Advancements and future directions in research of the roles of insulin in amyloid diseases
    Yifat Miller · 2021 · Biophysical Chemistry
  7. Association between the triglyceride-glucose index and cognitive impairment in China: a community population-based cross-sectional study
    Yimeng Ma, Shan Wei, Liangjun Dang, Ling Gao, Suhang Shang, Ningwei Hu, Wei Peng, Yi Zhao, Ye Yuan, Rong Zhou et al. · 2023 · Nutritional Neuroscience
  8. Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia
    Hiroyuki Umegaki · 2016 · Drugs & Aging
  9. Aberrant Brain Functional Connectivity Strength and Effective Connectivity in Patients with Type 2 Diabetes Mellitus
    Xi Guo, Su Wang, Yu‐Chen Chen, Heng‐Le Wei, Gang‐Ping Zhou, Yu‐Sheng Yu, Xindao Yin, Kun Wang, Hong Zhang · 2021 · Journal of Diabetes Research
  10. Circulating biomarkers that predict incident dementia
    Galit Weinstein, Sudha S. Seshadri · 2014 · Alzheimer s Research & Therapy
  11. Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers
    Xuan Shi, Takuya Miyakawa, Akira Nakamura, Feng Hou, Makoto Hibi, Jun Ogawa, Yeondae Kwon, Masaru Tanokura · 2017 · Scientific Reports
  12. Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients
    Saja S. Khuder, Suming Chen, Scott Lee Letendre, Thomas D. Marcotte, Igor Grant, Donald R Franklin, Leah H. Rubin, Joseph B. Margolick, Lisa P. Jacobson, Ned C Sacktor et al. · 2019 · Neurology
  13. Patients with Alzheimer’s Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid
    Alexandra Horváth, Zeinab Salman, Patrick S. Quinlan, Anders Wallin, Johan Svensson · 2020 · Journal of Alzheimer s Disease
  14. Cognitive impairment is correlated with insulin resistance degree: the “PA-NICO-study”
    Antonietta Fava, Carmen Colica, Massimiliano Plastino, Demetrio Messina, Dario Cristiano, Carlo Opipari, Antonio Vaccaro, Gaetano Gorgone, Francesca Bosco, Alessandra Fratto et al. · 2017 · Metabolic Brain Disease
  15. Could Nutrition Prevent the Onset of dementia? Current Evidence From Epidemiological and Intervention Studies
    Pascale Barberger‐Gateau, Cécilia Samieri, Benjamin Allès, Catherine Féart · 2012 · Neurodegenerative Disease Management
  16. Misfolded protein aggregation and altered cellular pathways in neurodegenerative diseases
    Huifang Li, Zhenghong Yu, Wei Zhang · 2020 · STEMedicine
  17. Measures of Adiposity and Alzheimer’s Disease-Related MRI Markers: The Northern Manhattan Study
    Michelle R. Caunca, Marialaura Simonetto, Noam J. Alperin, Mitchell S.V. Elkind, Ralph L. Sacco, Clinton B. Wright, Tatjana Rundek · 2019 · Journal of Alzheimer s Disease
  18. Neuroprotective role of curcumin on the hippocampus against the oxidative stress and inflammation of streptozotocin-induced diabetes in rats
    Mehmet ÖZSAN, Ülkü Saygılı Düzova, Nurcan Dönmez · 2024 · Metabolic Brain Disease
  19. Analysis of entropies based on empirical mode decomposition in amnesic mild cognitive impairment of diabetes mellitus
    Dong Yan Cui, Jinhuan Wang, Zhijie Bian, Qiuli Li, Lei Wang, Xiaoli Li A · 2014 · Journal of Innovative Optical Health Sciences
  20. Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study
    Anna Backeström, Sture Eriksson, Lars‐Göran Nilsson, Tommy Olsson, Olov Rolandsson · 2015 · Diabetology & Metabolic Syndrome
  21. Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance
    Caihong Zhu, Petra Schwarz, Irina Abakumova, Adriano Aguzzi · 2015 · PLoS ONE
  22. Comparative studies for amyloid beta degradation: “Neprilysin vs insulysin”, “monomeric vs aggregate”, and “whole Aβ40 vs its peptide fragments”
    Dai Kato, Yoshiaki Takahashi, Haruto Iwata, Yusuke Hatakawa, Seon Hwa Lee, Tomoyuki Oe · 2022 · Biochemistry and Biophysics Reports
  23. Diabetes Mellitus and Energy Dysmetabolism in Alzheimer’s Disease: Understanding the Relationships and Potential Therapeutic Targets
    Adejoke Y. Onaolapo, Folusho O. Ojo, Olufunto Omodele Adeleye, Joshua Falade, Olakunle J. Onaolapo · 2023 · Current Diabetes Reviews
  24. Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin
    Samira Rashtiani, Iran Goudarzi, Adele Jafari, Kambiz Rohampour · 2021 · Neuroscience Letters
  25. Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance
    Rabab Al‐Lahham, Nicolás Méndez · 2023 · Journal of Alzheimer s Disease
  26. The protective role of GLP-1 in neuro-ophthalmology
    Sohum Sheth, Aashay Patel, Marco A Foreman, Mohammed Mumtaz, Akshay Reddy, Ramy Sharaf, Siddharth Sheth, Brandon Peter Lucke-Wold · 2023 · Exploration of Drug Science
  27. Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer’s disease
    Brendan K. Ball, Jee Hyun Park, Alexander M. Bergendorf, Elizabeth A. Proctor, Douglas K. Brubaker · 2025 · npj Systems Biology and Applications
  28. Transcriptional Profiles Reveal Deregulation of Lipid Metabolism and Inflammatory Pathways in Neurons Exposed to Palmitic Acid
    Manuel Flores‐León, Nicolás Alcaraz, Martha Pérez‐Domínguez, Karla Torres‐Arciga, Rosa Rebollar‐Vega, Inti Alberto De La Rosa-Velázquez, Cristian Arriaga-Canon, Luis A. Herrera, Clorinda Arias, Rodrigo González‐Barrios · 2021 · Molecular Neurobiology
  29. Association between metabolic syndrome and incidence of ocular motor nerve palsy
    Daye Diana Choi, Kyungdo Han, Sei Yeul Oh, Kyung‐Ah Park · 2021 · Scientific Reports
  30. The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms
    Zihao Zhang, Ze-Hu Sheng, J Y Liu, Dandan Zhang, Hao Wang, Lanyang Wang, Yangke Zhu, Lingzhi Ma, Lan Tan · 2024 · Journal of Alzheimer s Disease
  31. Alzheimer's Disease: How Far Have We Progressed? Lessons Learned from Diabetes Mellitus, Metabolic Syndrome, and Inflammation
    Giovanni Viscogliosi, Vincenzo Marigliano · 2013 · Journal of the American Geriatrics Society
  32. Glycolytic metabolism supports microglia training during age-related neurodegeneration
    Alberto Camacho‐Morales · 2022 · Pharmacological Reports
  33. Parameters of glucose metabolism and the aging brain: a magnetization transfer imaging study of brain macro- and micro-structure in older adults without diabetes
    Abimbola A. Akintola, Annette van den Berg, Irmhild Altmann‐Schneider, Steffy W. M. Jansen, Mark A. van Buchem, P. Eline Slagboom, Rudi G. J. Westendorp, Diana van Heemst, Jeroen van der Grond · 2015 · AGE
  34. Sesamin suppresses advanced glycation end products induced microglial reactivity using BV2 microglial cell line as a model
    Sasimol Udomruk, Benjawan Wudtiwai, Thuzar Hla Shwe, Thanyaluck Phitak, Peraphan Pothacharoen, Mattabhorn Phimphilai, Prachya Kongtawelert · 2021 · Brain Research Bulletin
  35. Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
    Gilda E. Ennis, Rebecca L. Koscik, Yue Ma, Erin McMullen Jonaitis, Carol Ann Van Hulle, Tobey J. Betthauser, Allison M. Randall, Nathaniel A. Chin, Corinne D. Engelman, Rozalyn M. Anderson et al. · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  36. Vascular Health Is Associated With Functional Connectivity Decline in Higher-Order Networks of Older Adults
    Miranka Wirth, Malo Gaubert, Theresa Köbe, Antoine Garnier‐Crussard, Catharina Lange, Julie Gonneaud, Robin de Florès, Brigitte Landeau, Vincent de La Sayette, Gaël Chételat · 2022 · Frontiers in Integrative Neuroscience
  37. Amyloid beta-correlated plasma metabolite dysregulation in Alzheimer's disease: an untargeted metabolism exploration using high-resolution mass spectrometry toward future clinical diagnosis
    Jingzhi Yang, Shuo Wu, Jun Yang, Qun Zhang, Xin Wen Dong · 2023 · Frontiers in Aging Neuroscience
  38. Obesity and cognitive dysfunction
    М.В. Матвеева, Ю. Г. Самойлова, Natalija Grigorevna Zhukova · 2016 · Obesity and metabolism
  39. Retinal Microperimetry: A Useful Tool for Detecting Insulin Resistance-Related Cognitive Impairment in Morbid Obesity
    Andreea Ciudin, Ángel Ortiz-Zúñiga, Enzamaría Fidilio, Diana Romero, Marta Sánchez, Marta Comas, Óscar González, Ramón Vilallonga, Olga Simó‐Servat, Cristina Hernández et al. · 2019 · Journal of Clinical Medicine
  40. Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases
    Christian Hölscher · 2020 · International review of neurobiology
  41. Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study
    Emilia Vataja, Matti Viitanen, Juha O. Rinne, Jenni Lehtisalo, Iris Erlund, Tiia Ngandu, Seppo V. P. Koskinen, Fredrik O. Åberg, Antti Jula, Laura L. Ekblad · 2025 · Digestive and Liver Disease
  42. Microglia energy metabolism: A new perspective on Alzheimer's disease treatment
    Qing-Lin Wu, Xiong Yang, Jia-Xin Luo, Li Liu, Ya Zhou, Mei‐Hong Lu · 2025 · Journal of the Neurological Sciences
  43. The brain-joint axis: links between osteoarthritis and neurodegenerative disorders in aging
    Mostafa Adel Rabie, Henning Madry, Magali Cucchiarini, Nesrine S. El Sayed · 2025 · Journal of Advanced Research
  44. Dietary and pharmacological energy restriction and exercise for healthspan extension
    María Lastra Cagigas, Isabella De Ciutiis, Andrius Masedunskas, Luigi Fontana · 2025 · Trends in Endocrinology and Metabolism
  45. Markers of adiposity, insulin resistance, prediabetes and cognitive function at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA – Brasil)
    Mônica Maria Teixeira, Valéria Maria de Azeredo Passos, Sandhi Maria Barreto, María Inês Schmidt, Bruce Bartholow Duncan, Alline Maria R. Beleigoli, Maria de Jesus Mendes da Fonseca, Pedro Guatimosim Vidigal, Roberta Carvalho de Figueiredo, Enrico A. Colosimo et al. · 2020 · Diabetes Research and Clinical Practice
  46. Type 2 diabetes has a slow and insidious effect on cognition
    Hiroyuki Umegaki · 2015 · Nature Reviews Neurology
  47. The Fox and the Rabbits—Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease
    Christopher J. Carter · 2011 · ISRN Neurology
  48. Altered plasma visfatin levels and insulin resistance in patients with Alzheimer’s disease
    Ehsan Sharifipour, Soroush Sharifimoghadam, Navid Hassanzadeh, Negin Ghasemian Mojarad, Abdoreza Ghoreishi, Seyed Amir Hejazi, Kambiz Rohampour · 2019 · Acta Neurologica Belgica
  49. Synergistic Effect between Apolipoprotein E ε4 and Diabetes Mellitus for Dementia: Result from a Population-Based Study in Urban China
    Qianhua Zhao, Yunyun Xiong, Ding Ding, Qihao Guo, Zhen Hong · 2012 · Journal of Alzheimer s Disease
  50. Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease
    Suzanne M. de la Monte, Ming Tong · 2013 · Wiley eBooks
  51. Examining the effects of ovarian hormone loss and diet-induced obesity on Alzheimer’s disease markers of amyloid-β production and degradation
    Grant C. Hayward, Bradley J. Baranowski, Daniel M. Marko, Rebecca E. K. MacPherson · 2021 · Journal of Neurophysiology
  52. A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors
    Francesco Marotta, Massimiliano Giuseppe Marcellino, Umberto Solimene, Biagio Cuffari, Hariom Yadav, Alexander N. Khokhlov, Aldo Lorenzetti, Amelie Mantello, Joseph Cervi, Roberto Catanzaro · 2017 · Clinical Pharmacology & Biopharmaceutics
  53. Invited review: Unearthing the mechanisms of age-related neurodegenerative disease using Caenorhabditis elegans
    Ashley N. Hayden, Emily J Leptich, Rachel N. Arey · 2022 · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology
  54. A PDK-1 Allosteric Agonist Improves Spatial Learning and Memory in a ΒAPP/PS-1 Transgenic Mouse-High Fat Diet Intervention Model of Alzheimer's Disease
    Henry W. Querfurth, Angela Lucas Slitt, Amy DiCamillo, Nathan O. Surles, Brenton DeBoef, Hankyu Lee · 2022 · SSRN Electronic Journal
  55. Insulin and Sex Interactions in Older Adults with Mild Cognitive Impairment
    Brenna Cholerton, Laura D. Baker, Emily H. Trittschuh, Paul K. Crane, Eric Berg Larson, Matthew Arbuckle, Hector Hernandez Saucedo, Susan M. McCurry, James D. Bowen, Wayne C. McCormick et al. · 2012 · Journal of Alzheimer s Disease
  56. Relationship between Insulin Levels and Nonpsychotic Dementia: A Systematic Review and Meta-Analysis
    Qiu-xia Pan, Xiaojuan Li, Yue-yun Liu, Fang-fang Wang, Yajing Hou, Qinglai Bian, Wenqi Qiu, Zhiyi Yan, You-Ming Jiang, Jiaxu Chen · 2017 · Neural Plasticity
  57. A Comprehensive Analysis of Unique and Recurrent Copy Number Variations in Alzheimer’s Disease and its Related Disorders
    Fadia El Bitar, Nourah Alsudairy, Najeeb Qadi, Saad Al Rajeh, Fatimah Othman Alghamdi, Hala Abdulrahman Al Amari, Ghadeer Al Dawsari, Sahar Alsubaie, Mishael Al Sudairi, Sara Abdulaziz et al. · 2020 · Current Alzheimer Research
  58. Insulin resistance, age and depression’s impact on cognition in middle-aged adults from the PREVENT cohort
    Sarah Bauermeister, Michael Ben Yehuda, Graham Reid, Gregory Howgego, Karen A. Ritchie, Tam J. Watermeyer, Sarah Gregory, Graciela Muniz Terrera, Ivan G. Koychev · 2023 · BMJ Mental Health
  59. The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults
    Gilda E. Ennis, Akshay Kohli, Erin McMullen Jonaitis, Tobey J. Betthauser, Jennifer M. Oh, Chase E. Taylor, Nathaniel A. Chin, Rebecca L. Koscik, Bradley T. Christian, Sanjay Asthana et al. · 2021 · Neurobiology of Aging
  60. Relationship between cognitive impairment and serum amyloid β-protein, adiponectin, and C-reactive protein levels in type II diabetes patients
    Haiju Liu, Ji Ma, Li Sun, Qin Zhang, Jiubo Fan · 2021 · Annals of Palliative Medicine
  61. Late life insulin resistance and Alzheimer's disease and dementia: The Kuakini Honolulu heart program
    Thomas Ho-yin Lee, Eric L. Hurwitz, Robert V. Cooney, Yan Yan Wu, Chen‐Yen Wang, Kamal Masaki, Andrew Grandinetti · 2019 · Journal of the Neurological Sciences
  62. Study of lipids, insulin metabolism, and paraoxonase-2-311 polymorphism in patients with different subtypes of Alzheimer's disease (translated version).
    N Mu, Shuchang Xu, Q Chang, D P Rao, Jieping Chen, Cao Ma · 2013 · PubMed
  63. Arg972 insulin receptor substrate-1 polymorphism and risk and severity of Alzheimer’s disease
    Wei Wang, Liang Yang, Liming Tan, Xiaomei Wu, Bo Jiang, Xiangmin Shen · 2013 · Journal of Clinical Neuroscience
  64. Causal association between insulin sensitivity index and Alzheimer's disease
    Fang Xu, Shiyang Wu, Shan Gao, Xuan Li, Chen Huang, Yan Chen, Ping Zhu, Guiyou Liu · 2024 · Journal of Neurochemistry
  65. Evidence from NHANES 2011–2014: a correlation between the weight-adjusted-waist index and cognitive abilities in the United States
    Chan Zhao, Xintian Xu, Chunyan Hao · 2025 · Frontiers in Aging Neuroscience
  66. Cognitive impairments in patients with overweight and obesity
    И. А. Черевикова, N. A. Myasishchev, V. M. Polyakov, Lyubov Vladimirovna Rychkova · 2021 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
  67. Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article
    Nezar Y. Albar, H. Hassaballa, Hamza Shikh, Yassin Albar, Abdullatif Sheikh Ibrahim, Ahmed Hafez Mousa, Asim Muhammed Alshanberi, Ahmed Saber Elgebaly, Eshak I. Bahbah · 2024 · Postgraduate Medicine · Retracted
  68. Alzheimer’s Disease and Type 2 Diabetes: Different Pathologies and Same Features
    Marta Di, Pasquale Picone, Rita Carrotta, Daniela Giacomazza, P.L. San · 2011 · InTech eBooks
  69. Serum thyroid-stimulating hormone level and relation with size of hippocampus in patients with mild cognitive disorders
    Pegah Ahmadi, Mohammad-Hossein Daghighi, Masoud Poureisa, Mahmoud Reshadatjoo, Sahar Golestani, Mohammad Naghavi‐Behzad, Farid Karkon Shayan · 2016 · Nigerian Medical Journal
  70. Leveraging Electronic Medical Records and Knowledge Networks to Predict Disease Onset and Gain Biological Insight Into Alzheimer’s Disease
    Alice Tang, Katherine P. Rankin, Gabriel Cerono, Silvia Miramontes, Hunter Mills, Jacquelyn M. Roger, Billy Zeng, Charlotte Nelson, Karthik Soman, Sarah R. Woldemariam et al. · 2023 · medRxiv
  71. Diabetes and Hypertension
    Clinton B. Wright, Michelle R. Caunca · 2020 · Springer eBooks
  72. Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
    Antoni Camins, Miren Ettcheto, Oriol Busquets · 2019 · Neural Regeneration Research
  73. Pyrosequencing analysis of IRS1 methylation levels in schizophrenia with tardive dyskinesia
    Yanli Li, Kesheng Wang, Ping Zhang, Junchao Huang, Ying Liu, Zhiren Wang, Yongke Lu, Shuping Tan, Fude Yang, Yunlong Tan · 2020 · Molecular Medicine Reports
  74. Impaired Early Insulin Response to Glucose Load Predicts Episodic Memory Decline: A 10-Year Population-Based Cohort Follow-Up of 45–74-Year-Old Men and Women
    Sini Toppala, Laura L. Ekblad, Matti H. Viitanen, Juha O. Rinne, Antti Jula · 2023 · Journal of Alzheimer s Disease
  75. Mild Cognitive Impairment Detection Using Association Rules Mining
    František Babič, Ľudmila Pusztová, Ljiljana Trtica Majnarić · 2020 · Acta Informatica Pragensia
  76. Diabetes and Hypertension
    Lenore J. Launer, Clinton B. Wright · 2009 · Springer eBooks
  77. Are you TORCing tau me? Amyloid‐β blocks the conversation between lysosomes and mitochondria
    Juan Carlos Polanco, Jürgen Götz · 2018 · The EMBO Journal
  78. Expression of MAPK and inflammasomes in cells of the brain in experimental Alzheimer's disease
    Yana V. Gorina, Olga L. Lopatina, Yuliya К. Komleva, Черных Анатолий Игоревич, Alla B. Salmina · 2017 · Annals of Clinical and Experimental Neurology
  79. Oxidative stress and metabolic syndrome in Alzheimer’s disease: the search for a relationship
    N. M. Zalutskaya, Elena E. Dubinina, N. A. Gomzyakova, Константин Владимирович Ющин, Н. Г. Незнанов · 2024 · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
  80. Neuropsychiatric Disorders Among Aging Women: Assessing Risk Factors and Tailoring Treatment
    Sarah B. Mathews, Cynthia Neill Epperson · 2015 · Current Behavioral Neuroscience Reports
  81. Management of Diabetes in Elderly
    Bernard Bauduceau, L. Bordier · 2017 · International Journal of Medicine and Surgery
  82. Glucose and Ketone Metabolism in the Aging Brain
    Stephen C. Cunnane, Alexandre Courchesne‐Loyer, Valérie St‐Pierre, Camille Vandenberghe, Étienne Croteau, Christian‐Alexandre Castellano · 2016
  83. Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort
    Kirsten Mehlig, Ronja Foraita, Rajini Nagrani, Marvin N. Wright, Stefaan De Henauw, Dénes Molnár, Luis Alberto Moreno, Paola Russo, Michael J. Tornaritis, Toomas Veidebaum et al. · 2023 · Diabetologia
  84. Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study
    Cathleen Morgan, Bradon Annegers, Matthew Taylor, Sara Shuger Fox, Tyler J. Titcomb · 2024 · European Journal of Neurology
  85. Biomarkers and Risk Factors of Dementia
    Elisabeth M. C. Schrijvers · 2011 · RePub (Erasmus University Rotterdam)
  86. Analysis of Link between Brain Insulin Resistance and Alzheimer's Disease: A Systematic Review
    Luís Jesuíno de Oliveira Andrade, Luís Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Letícia Góes de Carvalho Lourenço, Gabriela Correia Matos de Oliveira · 2023 · Research Square
  87. Glucagon-like peptide-1 receptor agonists: prospects for use in the treatment of age-related diseases and aging
    Natalia Bobok, Oleksandr A. Halushko · 2025 · Problems of ageing and longevity (Ukraine)
  88. Association of circulating branched-chain or aromatic amino acids based on metabolome and apolipoprotein E genotype with incident dementia: a large cohort study
    Yang Liu, Yongjun Ai, Yinyin Wu, Yuncheng Zhang, Jianian Hua, Tong Liu, Dong Liu, Guo-Chong Chen, Guangfei Xu, Li-Hua Chen · 2026 · International Journal of Food Sciences and Nutrition
  89. Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles
    Naotaka Izuo, Hiroshi Kondoh, Takahiko Shimizu · 2026 · Geriatrics and gerontology international/Geriatrics & gerontology international
  90. Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology
    Kao Lee Yang, Yue Ma, Gilda E. Ennis, Erin Jonaitis, Ramiro Eduardo Rea Reyes, Sterling C. Johnson, Nicholas James Ashton, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  91. Analogues du GLP-1 et éducation du patient diabétique de type 2
    F. Lagrange · 2011 · Le Pharmacien Hospitalier
  92. Les troubles cognitifs chez les patients diabétiques âgés. Apport de l’étude Gérodiab
    Bernard Bauduceau, L. Bordier, Jean Pierre Le Floch, Christiane Verny, J. Doucet · 2016 · Bulletin de l Académie Nationale de Médecine
  93. Precision Nutrition in Aging and Brain Health
    Stephen T. Chen, Gary W. Small · 2023 · Elsevier eBooks
  94. Metabolic factors associated with plasma phosphorylated tau analytes used to detect Alzheimer’s disease pathology
    Kao Lee Yang, Yue Ma, Gilda E. Ennis, Erin McMullen Jonaitis, Ramiro Eduardo Rea Reyes, Sterling C. Johnson, Nicholas James Ashton, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin · 2025 · medRxiv
  95. Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes
    LaShae Nicholson, Si Jie Tang, Tejaswini Karra, Habiba Abouelatta, Stephen M. Strittmatter · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. The Effect of Cardiovascular Stress on Cognition and Mortality : Studies on B-type Natriuretic Peptide amongst the Elderly Population
    Matti Hiltunen · 2014 · Työväentutkimus Vuosikirja
  97. Modulation of Cognition by Insulin and Aging: Implications for Alzheimer Disease
    Maite Solas, María Javier Ramírez · 2013
  98. Current conceptions of the etiology and risk factors for Alzheimer’s disease and their possible implications on the design of dementia clinical trials
    Ramit Ravona‐Springer, Amos D. Korczyn · 2011 · Clinical Investigation
  99. Neuropsychologie et santé
    Zina Barrou · 2014 · Dunod eBooks
  100. Neuroprotective effects of Resveratrol against oxidative stress and memory impairment in vivo and in vitro
    Shraddha D. Rege · 2016